Phosphagenics Ltd. said Peter Lankau retired from the company's board.
The nonexecutive director joined the Melbourne, Australia-based biotechnology company's board in 2015.
Phosphagenics nonexecutive director retires
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Phosphagenics Ltd. said Peter Lankau retired from the company's board.
The nonexecutive director joined the Melbourne, Australia-based biotechnology company's board in 2015.